Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.150
-0.060 (-4.96%)
At close: Dec 5, 2025, 4:00 PM EST
1.170
+0.020 (1.74%)
After-hours: Dec 5, 2025, 7:56 PM EST
Canopy Growth Market Cap
Canopy Growth has a market cap or net worth of $394.94 million as of December 5, 2025. Its market cap has decreased by -1.09% in one year.
Market Cap
394.94M
Enterprise Value
366.63M
1-Year Change
-1.09%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since May 24, 2018, Canopy Growth's market cap has decreased from $5.67B to $394.94M, a decrease of -93.03%. That is a compound annual growth rate of -29.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 414.10M | 43.44% |
| Dec 31, 2024 | 288.70M | -31.86% |
| Dec 29, 2023 | 423.70M | -62.25% |
| Dec 30, 2022 | 1.12B | -67.34% |
| Dec 31, 2021 | 3.44B | -62.54% |
| Dec 31, 2020 | 9.17B | 26.27% |
| Dec 31, 2019 | 7.26B | 34.51% |
| Dec 31, 2018 | 5.40B | -4.72% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |